4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000253
Director sold 667 shares at $80.86 ($53,934)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Malady Kyle Director | 2025-09-05 | Sale 10b5-1 | −667 | $80.86 | $53,934 | 22,667 | D |
| Open-market sales · 667 sh · avg $80.86 · $53,934 | |||||||
Loading xslF345X05/wk-form4_1757449097.xml…